Effectiveness of Ayurvedic Interventions in the Management of Raktapradar (Asrigdara): A Systematic Review
DOI:
https://doi.org/10.47070/ayushdhara.v13i1.2415Keywords:
Asrigdara, Raktapradar, Abnormal Uterine Bleeding, Ayurvedic Management, Shamana Chikitsa, Shodhana ChikitsaAbstract
Asrigdara (Raktapradar) is a common gynaecological disorder described in Ayurveda, characterized by excessive or prolonged menstrual bleeding due to vitiation of Rakta predominantly associated with Pitta and Vata Dosha. It closely correlates with abnormal uterine bleeding (AUB) in contemporary medicine and significantly affects women’s physical and psychological well-being. Although several clinical studies have explored the role of Ayurvedic interventions in the management of Asrigdara, the evidence remains dispersed across various sources. The present systematic review aims to evaluate and synthesize clinical evidence regarding the effectiveness of Ayurvedic interventions in the management of Asrigdara (Raktapradar). A comprehensive literature search was conducted using electronic databases including PubMed, Google Scholar, AYUSH Research Portal, and indexed Ayurvedic journals. Clinical studies such as randomized controlled trials, non-randomized trials, and single-arm studies were included for analysis. The reviewed studies demonstrated significant improvement in clinical outcomes, including reduction in menstrual blood loss and duration, improvement in menstrual regularity, and increase in haemoglobin levels. Ayurvedic interventions comprising Shamana Chikitsa with Rakta-stambhaka and Garbhashaya-balya formulations, along with Shodhana Chikitsa such as Virechana and Basti Karma, were found to be effective and well tolerated. The combined use of Shodhana followed by Shamana therapy showed better and sustained outcomes, particularly in chronic and recurrent cases.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 AYUSHDHARA

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
